Literature DB >> 32893029

Survival outcomes in patients with cervical cancer treated with open versus robotic radical hysterectomy: Our surgical pathology interrogation.

Jie Yang1, Carolyn Mead-Harvey2, Clarissa Polen-De3, Paul Magtibay4, Kristina Butler4, William Cliby3, Carrie Langstraat3, Tri Dinh5, Longwen Chen6, Javier Magrina7.   

Abstract

OBJECTIVE: To compare the survival outcomes and surgical radicality between women who underwent open versus robotic radical hysterectomy (RH) for early cervical cancer.
METHODS: In this institutional retrospective study, patients with clinical stage IA2- IIA (FIGO 2009) squamous cell, adenocarcinoma and adenosquamous carcinoma of the cervix who underwent either open or robotic RH between 2000 and 2017 were identified. Parametrial width and vaginal length were re-measured from pathology slides. An inverse propensity score weighting model was used to adjust selection bias.
RESULTS: A total of 333 patients were included (181 open, 152 robotic). The median follow-up time was 130 months for the open group and 53 months for the robotic group. There were 31 (17.1%) recurrences in the open and 21 (13.8%) in the robotic group. The 5-year progression-free survival (PFS) for the robotic and open group were 79.0% and 90.5%, respectively (HR 2.37, 95% CI 1.40-4.02). Five-year overall survival (OS) were 85.8% and 95.3%, respectively (HR 3.17, 95% CI 1.76-5.70). The mean parametrial width was similar between the open and robotic groups (2.5 vs 2.4 cm, p = 0.99). Unique recurrences (38.1%, 8/21) were noted in the robotic group: 2 port-site, 4 peritoneal, and 2 carcinomatosis. The time to vaginal recurrence was shorter in the robotic group than the open group (p = 0.001).
CONCLUSION: Patients who underwent robotic RH had inferior PFS and OS compared to open surgery. Surgical radicality according to pathology measurements was similar between the two approaches. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2020        PMID: 32893029     DOI: 10.1016/j.ygyno.2020.08.031

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

Review 1.  Minimally Invasive Surgery for Cervical Cancer in Light of the LACC Trial: What Have We Learned?

Authors:  Omar Touhami; Marie Plante
Journal:  Curr Oncol       Date:  2022-02-14       Impact factor: 3.677

2.  Comparison of Minimally Invasive Versus Abdominal Radical Hysterectomy for Early-Stage Cervical Cancer: An Updated Meta-Analysis.

Authors:  Mengting Zhang; Wei Dai; Yuexiu Si; Yetan Shi; Xiangyuan Li; Ke Jiang; Jingyi Shen; Liying Ying
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 6.244

Review 3.  Management of Early-Stage Cervical Cancer: A Literature Review.

Authors:  Yasmin Medeiros Guimarães; Luani Rezende Godoy; Adhemar Longatto-Filho; Ricardo Dos Reis
Journal:  Cancers (Basel)       Date:  2022-01-24       Impact factor: 6.639

4.  Survival Impact of Residual Cancer Cells in Intraoperative Peritoneal Washes following Radical Hysterectomy for Cervical Cancer.

Authors:  Jong Mi Kim; Gun Oh Chong; Nora Jee-Young Park; Yeong Eun Choi; Juhun Lee; Yoon Hee Lee; Dae Gy Hong; Ji Young Park
Journal:  J Clin Med       Date:  2022-05-09       Impact factor: 4.241

Review 5.  A meta-analysis of survival after minimally invasive radical hysterectomy versus abdominal radical hysterectomy in cervical cancer: center-associated factors matter.

Authors:  Si Sun; Jing Cai; Ruixie Li; Yujia Wang; Jing Zhao; Yuhui Huang; Linjuan Xu; Qiang Yang; Zehua Wang
Journal:  Arch Gynecol Obstet       Date:  2022-01-21       Impact factor: 2.493

6.  Survival Outcomes in Patients With 2018 FIGO Stage IA2-IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis.

Authors:  Wancheng Zhao; Yunyun Xiao; Wei Zhao; Qing Yang; Fangfang Bi
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.